Urolithin A in Your 70s: Strength, Energy & Independence

Your seventies are a decade where small advantages in energy, strength and steadiness add up to something large: the ability to keep doing the things you want to do, on your own terms. Urolithin A is one of the few longevity ingredients with human trial data in exactly this age group, and this guide explains honestly what it can and cannot do.

Why the seventies are different

By the time most people reach their seventies, two quiet processes have been underway for decades. The first is a gradual loss of muscle mass and power that scientists call sarcopenia; the second is a decline in how well mitochondria — the tiny energy factories inside every cell — convert food and oxygen into usable energy. These are not the same thing, but they feed each other. Muscle fibres are among the most mitochondria-dense tissues in the body, so when mitochondrial output slips, muscle tends to tire faster and recover more slowly. The result is familiar: stairs feel steeper, grocery bags feel heavier, and an afternoon of errands leaves you wanting a longer rest than it used to.

None of this is a disease in itself. It is a feature of normal aging that varies enormously from person to person, and it is strongly shaped by how much you move. But it does explain why an ingredient aimed directly at mitochondrial quality has drawn so much interest from researchers studying people over 65. If the energy machinery inside muscle cells could be kept cleaner and more efficient, the reasoning goes, some of the functional slide might soften. That is a reasonable hypothesis to test — and, unusually for the supplement world, it has actually been tested.

What urolithin A is, in plain terms

Urolithin A is not a vitamin or a plant extract you swallow directly. It is a postbiotic: a compound your gut bacteria make when they break down ellagitannins and ellagic acid found in foods such as pomegranates, walnuts and certain berries. The catch is that the gut bacteria capable of this conversion are not universal. Studies suggest only a minority of adults — often cited as around a third — produce meaningful amounts of urolithin A from food alone, and that fraction does not reliably improve with age. That gap between the theoretical food source and the amount your body actually makes is the entire reason a standardized supplement exists. If you want to know whether you are a natural producer, our explainer on urolithin A producers and gut bacteria walks through it.

Once absorbed, urolithin A's best-studied action is supporting mitophagy — the cell's housekeeping routine for identifying worn-out mitochondria and recycling their parts so that fresher, better-functioning ones can take their place. Think of it less as adding horsepower and more as clearing the clutter so the engine you have runs cleaner. For a fuller mechanism walkthrough, see our complete urolithin A guide.

The human evidence that matters most for this age group

The single most relevant study for a reader in their seventies is a randomized, placebo-controlled trial published in JAMA Network Open in 2022 (Liu, D'Amico and colleagues). It enrolled adults aged 65 to 90 who were living independently, and had them take 1,000 mg of urolithin A daily for four months. This is a genuine human trial in older people, not a mouse study, which makes it worth describing carefully.

The encouraging findings: participants taking urolithin A showed measurable improvements in muscle endurance in both the hand and the leg compared with placebo, and the gap widened from month two to month four. Several blood markers also moved in a favourable direction — certain acylcarnitines and ceramides, which can signal mitochondrial strain, fell significantly, and C-reactive protein, a general marker of inflammation, dropped in the urolithin A group while it did not budge on placebo.

The honest caveats are just as important. A six-minute walk test improved in both groups, with no significant difference between them, and a direct measure of maximal ATP production in muscle did not change significantly over the four months. In other words, the trial supported improvements in muscle endurance and some biomarkers of mitochondrial and inflammatory status, but it did not demonstrate a jump in raw energy output or walking distance. The study was also funded by a company that sells the ingredient, the sample was demographically narrow, and the authors themselves called for larger, longer and more diverse trials. That is exactly the kind of mixed, real-world result you should expect from honest science — meaningful signals in a few outcomes, null results in others.

Supporting this, an earlier first-in-human study (Andreux et al., 2019, Nature Metabolism) established that urolithin A was safe and well tolerated at doses up to 1,000 mg per day and produced a mitochondrial gene-expression signature in muscle, and a 2022 trial in middle-aged adults (Singh et al., Cell Reports Medicine) reported improvements in muscle strength and aspects of exercise performance over four months at 500 mg and 1,000 mg daily. A 2024 systematic review in Ageing Research Reviews gathered this human work together and concluded the ingredient is promising for muscle and mitochondrial endpoints while emphasising that the field is young.

What is still preclinical — and why that word matters

A lot of the most exciting-sounding claims about urolithin A come from research in cells and animals, not people. The foundational work by Ryu and colleagues (2016, Nature Medicine) showed that urolithin A extended lifespan in the worm C. elegans and improved muscle function in rodents through enhanced mitophagy. Early or preclinical research is also exploring roles in joint and cartilage health, brain, heart, skin and metabolic tissue. This is genuinely interesting groundwork, but a result in a mouse is a hypothesis about humans, not a promise. When you read a bold headline about urolithin A "doing" something, the first question worth asking is whether the study was in people. For this age group, the muscle-endurance and biomarker findings in the human trials are the parts standing on the firmest ground.

How to use it sensibly after 70

The dose used in the older-adult trial was 1,000 mg daily, and the broader clinically studied range is 500 to 1,000 mg per day. Consistency appears to matter more than timing: the benefits in the trials emerged over two to four months of daily use, so this is not a supplement you judge after a week. Taking it at the same time each day — many people pair it with breakfast — makes the habit easier to keep. For more on timing, our page on the best time to take urolithin A covers the details.

Format is a practical consideration that gets underrated in your seventies. Large capsules can be genuinely hard to swallow, and pill fatigue is real when you may already be managing other daily supplements or medications. A gummy sidesteps both problems, which is part of why SOMA HEALTH built its product that way. Whatever brand you choose, look for third-party testing and a transparent, full-strength dose rather than a pixie-dust sprinkle; our ranking of the best urolithin A gummies explains what to check.

Urolithin A is a support for an active life, not a substitute for one. The clearest lever on muscle and mitochondrial health at any age is movement — particularly a mix of resistance work and walking — and the trials were run in people who were still active. Think of the supplement as something that may help you get a little more from the effort you are already putting in.

Who should check with a doctor first

This is educational information about healthy aging, not medical advice, and urolithin A is not a treatment for sarcopenia, frailty, or any medical condition. If you take prescription medications, have kidney or liver concerns, or are managing a chronic condition, talk with your doctor or pharmacist before starting any new supplement — that is simply good practice in your seventies, when more people are on multiple medications. A clinician who knows your history is the right person to weigh it for you.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.